Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.

Wheat LJ, Nguyen MH, Alexander BD, Denning D, Caliendo AM, Lyon GM, Baden LR, Marty FM, Clancy C, Kirsch E, Noth P, Witt J, Sugrue M, Wingard JR.

J Clin Microbiol. 2014 Jun;52(6):2108-11. doi: 10.1128/JCM.03500-13. Epub 2014 Apr 9.

2.

Insufficient demonstration of long-term stability of Aspergillus galactomannan.

Johnson GL, Sarker SJ, Bustin SA, Agrawal SG.

J Clin Microbiol. 2014 Nov;52(11):4118. doi: 10.1128/JCM.02342-14. No abstract available.

3.

Reply to "Insufficient demonstration of long-term stability of Aspergillus galactomannan".

Wheat LJ, Nguyen MH, Alexander BD, Denning D, Caliendo AM, Lyon GM, Baden LR, Marty FM, Clancy C, Kirsch E, Noth P, Witt J, Sugrue M, Wingard JR.

J Clin Microbiol. 2014 Nov;52(11):4119. doi: 10.1128/JCM.02433-14. No abstract available.

4.

Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid.

Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, LeMonte AM, Durkin MM, Knox KS, Hage CA, Bentsen C, Singh N, Wingard JR, Wheat LJ.

Clin Vaccine Immunol. 2008 Dec;15(12):1760-3. doi: 10.1128/CVI.00226-08. Epub 2008 Oct 8.

5.

Instability of Aspergillus galactomannan in stored clinical samples.

Dufresne SF, Beauchemin S, Lavallée C, Laverdière M.

J Clin Microbiol. 2014 Dec;52(12):4435-6. doi: 10.1128/JCM.01912-14. Epub 2014 Sep 24. No abstract available. Erratum in: J Clin Microbiol. 2015 Feb;53(2):756.

6.

Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.

Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E, Fuso L, De Pascale G, Bello G, Antonelli M, Fadda G, Posteraro B.

J Clin Microbiol. 2011 Dec;49(12):4273-8. doi: 10.1128/JCM.05026-11. Epub 2011 Oct 19.

7.

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.

Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA.

J Clin Microbiol. 2004 Dec;42(12):5517-22.

8.

Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis.

Izumikawa K, Yamamoto Y, Mihara T, Takazono T, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yanagihara K, Mine M, Yasuoka A, Tashiro T, Kohno S.

Med Mycol. 2012 Nov;50(8):811-7. doi: 10.3109/13693786.2012.682228. Epub 2012 May 9.

PMID:
22568603
9.

Galactomannan testing of bronchoalveolar lavage fluid is useful for diagnosis of invasive pulmonary aspergillosis in hematology patients.

Hsu LY, Ding Y, Phua J, Koh LP, Chan DS, Khoo KL, Tambyah PA.

BMC Infect Dis. 2010 Mar 3;10:44. doi: 10.1186/1471-2334-10-44.

10.
11.
12.

Aspergillus galactomannan testing in patients with long-term neutropenia: implications for clinical management.

Penack O, Rempf P, Graf B, Blau IW, Thiel E.

Ann Oncol. 2008 May;19(5):984-9. doi: 10.1093/annonc/mdm571. Epub 2008 Jan 27.

PMID:
18227109
13.

Utility of Aspergillus antigen detection in specimens other than serum specimens.

Klont RR, Mennink-Kersten MA, Verweij PE.

Clin Infect Dis. 2004 Nov 15;39(10):1467-74. Epub 2004 Oct 26. Review.

PMID:
15546083
14.

Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.

Heng SC, Morrissey O, Chen SC, Thursky K, Manser RL, Nation RL, Kong DC, Slavin M.

Crit Rev Microbiol. 2015 Feb;41(1):124-34. doi: 10.3109/1040841X.2013.804033. Epub 2013 Jun 25. Review.

PMID:
23799871
15.

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.

Vergidis P, Razonable RR, Wheat LJ, Estes L, Caliendo AM, Baden LR, Wingard JR, Baddley J, Assi M, Norris S, Chandrasekar P, Shields R, Nguyen H, Freifeld A, Kohler R, Kleiman M, Walsh TJ, Hage CA.

J Clin Microbiol. 2014 Jun;52(6):2199-201. doi: 10.1128/JCM.00285-14. Epub 2014 Apr 9.

16.

Independent contribution of bronchoalveolar lavage and serum galactomannan in the diagnosis of invasive pulmonary aspergillosis.

Fisher CE, Stevens AM, Leisenring W, Pergam SA, Boeckh M, Hohl TM.

Transpl Infect Dis. 2014 Jun;16(3):505-10. doi: 10.1111/tid.12211. Epub 2014 Apr 12.

17.

Quantitative Real-Time PCR and Platelia Galactomannan Assay for the Diagnosis of Invasive Pulmonary Aspergillosis: Bronchoalveolar Lavage Fluid Performs Better Than Serum in Non-neutropaenic Patients.

Zhang S, Wang S, Wan Z, Que C, Li R, Yu J.

Mycopathologia. 2016 Oct;181(9-10):625-9. doi: 10.1007/s11046-016-0024-5. Epub 2016 Jun 7.

PMID:
27270570
18.

False-positive serum and bronchoalveolar lavage Aspergillus galactomannan assays caused by different antibiotics.

Boonsarngsuk V, Niyompattama A, Teosirimongkol C, Sriwanichrak K.

Scand J Infect Dis. 2010 Jul;42(6-7):461-8. doi: 10.3109/00365541003602064.

PMID:
20192889
19.
20.

Aspergillus galactomannan antigen in the bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in lung transplant recipients.

Husain S, Paterson DL, Studer SM, Crespo M, Pilewski J, Durkin M, Wheat JL, Johnson B, McLaughlin L, Bentsen C, McCurry KR, Singh N.

Transplantation. 2007 May 27;83(10):1330-6.

PMID:
17519782

Supplemental Content

Support Center